AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04898855 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Treatment includes sleep hygiene, sleep restriction, stimulus control, and cognitive therapy.
Study NCT05984875 — intervention group
Intervention type: OTHER
Intervention: Collection of tumor samples, blood and vaginal and rectal swabs
Description: The following biological samples will be collected at different time points, according to the specified cohort and after signing the inform consent form: tumor tissue (fresh and archival) or normal tissue (cohort E), ascites (when present), peripheral blood, rectal swab, vaginal swab.
Study NCT05782959 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCD-245
Description: BCD-245 is administered as prolonged intravenous infusions during each cycle
Study NCT06293404 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Bupivacain
Description: 7.5 mg Bupivacaine hydrochloride (0.5% heavy Marcaine) will be used on spinal anesthesia. (each group)
Study NCT04773860 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Energy Techniques
Description: A 4 week intervention will be carried out consisting of Muscle Energy Techniques on the accessory muscle of respiration. That is, Pectoralis Minor, Sternocleidomastoid, Upper trapezius, Scalene muscles and Latissimus Dorsi
Study NCT06037395 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CT-P41
Description: a single 60 mg subcutaneous (SC) injection via pre-filled syringe (PFS)
Study NCT06037395 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: US-licensed Prolia
Description: a single 60 mg subcutaneous (SC) injection via pre-filled syringe (PFS)
Study NCT06278467 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: visual pain scale (VASpain/fatigue), Beck depression index (BDI),
Description: VAS (0-10)
Study NCT06278467 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pain catastrophizing scale, sleep quality with a single Likert type question in the Pittsburgh questionnaire
Description: PCS (Pain catastrophizing scale); sleep quality with a single Likert type question in the Pittsburgh questionnaire (0-3)
Study NCT06278467 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36),
Description: functional disability level with Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36)
Study NCT06278467 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Montreal Cognitive Assessment Scale (MOCA); Standard Mini mental test (SMMT)
Description: cognitive status was measured by Montreal Cognitive Assessment Scale (MOCA) and Standard Mini mental test (SMMT)
Study NCT04755127 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic synovectomy of the wrist
Description: Wrist arthroscopy in day surgery setting with debulking of synovitis, inspection of cartilage, ligament, tendon and bone damage, collection of synovial biopsies and deposition of intra-articular corticosteroids (40mg triamcinolone acetonide)
Study NCT04755127 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular corticosteroid injection
Description: Injection with 40mg triamcinolone acetonide (kenacort) in the wrist
Study NCT05263401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3-hydroxybutyrate
Description: Orally administered pre-meal drinks.
Study NCT05986253 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed
Study NCT05986253 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: maltodextrin solution
Study NCT05986253 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Maltodextrin
Description: maltodextrin solution
Study NCT05779423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Monoclonal antibody administered through intravenous infusion
Study NCT05779423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Monoclonal antibody administered through intravenous infusion
Study NCT05779423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Procedure of freezing a tumor performed via CT-guidance by interventional radiologist.
Study NCT05263401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: 3-hydroxybutyrate
Description: Orally administered pre-meal drinks.
Study NCT05331196 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Preoperative cardiopulmonary exercise tetsing
Description: Patients underwent a cardiopulmonary exercise test prior to surgery.
Study NCT05360940 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: H.pylori stool antigen rapid test and stool parasitological examination
Description: 200 stool samples ( 100 positive and 100 negative for H.pylori) after performance of H.pylori stool rapid antigen test then parasitological stool examination will be done
Study NCT05130398 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rVSVΔG-ZEBOV-GP, V920
Description: The experimental vaccine is the rVSVΔG-ZEBOV-GP, an Ebola vaccine.
Study NCT05130398 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fibre and equilibrate breakfast and lunch
Description: Participants receive fibres and caloric equilibrate diet during breakfast and lunch every day for 21 consecutive days.
Study NCT05130398 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Active detection and treatment of pathogens
Description: Monthly diagnostic and treatment of childhood infections Active detection and treatment of pathogens.
Study NCT05130398 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Fibre and equilibrate breakfast and lunch plus Active detection and treatment of pathogens
Description: Participants receive fibres and caloric equilibrate diet during breakfast and lunch every day for 21 consecutive days and diagnostic and treatment of childhood infections Active detection and treatment of pathogens every month for 12 months
Study NCT05130398 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Chikenpox or Varicella vaccine (VARILRIX)
Description: The active comparator vaccine, a Varicella vaccine (VARILRIX®)
Study NCT05130398 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: About 30 children do not receive diet, nor active pathogen detection
Study NCT05443789 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor education
Description: A 15 minutes (preferable) one-on-one educational visit about deprescription of proton pump inhibitor
Study NCT05443789 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Other education
Description: A 15 minutes (preferable) one-on-one educational visit about another topic (NOT asthma).
Study NCT01303107 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: single dose of 15 mg by a slow injection rate of 1 mL/s
Study NCT01303107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: single dose of 15 mg by a slow injection rate of 1 mL/s
Study NCT05349916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: 300 g rice porridge + 150 ml drinking water
Study NCT05349916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isomaltodextrin Low Dose
Description: 300 g rice porridge + (5 g IMD in 150 ml drinking water)
Study NCT05349916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isomaltodextrin High Dose
Description: 300 g rice porridge + (10 g IMD in 150 ml drinking water)
Study NCT05349916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GPC partially digestible maltodextrin
Description: 300 g rice porridge + (15 g GPC fiber in 150 ml drinking water)
Study NCT05349916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistant Starch Type 4
Description: 300 g rice porridge + (15 g RS4 starch in 150 ml drinking water)
Study NCT04592315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lipovirtide Injection
Description: Single dosage of Lipovirtide Injection
Study NCT05804994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Elgydium Clinic Sensileave Gel (V063B - DP3003)
Description: Tested product is applied/used only once a day before whitening tray wear.
Study NCT04745689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: IV infusions through induction phase.~IV infusions through maintenance phase until PD or other discontinuation criteria.
Study NCT04745689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD2811
Description: IV infusions through maintenance phase until PD or other discontinuation criteria.
Study NCT04745689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusions through induction phase if chosen by Investigator.
Study NCT04745689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: IV infusions through induction phase if chosen by Investigator.
Study NCT04745689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: IV infusions through induction phase.
Study NCT05479071 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Screening of antibodies against LDL
Study NCT05468827 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lymphatic mapping with indocyanine green
Description: subserosal injection of indocyanine green near the primary tumour with subsequent assessment of the dye spread along lymphatics
Study NCT05267145 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: blood preservation solution III
Description: Blood bag added blood preservation solution III
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Case report form
Description: Sociodemographic information (age, gender, height, body mass index, marital status, occupation, education level, contact information), frequency of smoking and alcohol use, frequency of caffeine consumption, frequency of salt consumption, dominant side, background, family history, medical and audiological information were recorded.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Tinnitus disability scale
Description: Tinnitus disability scale was used to evaluate the tinnitus severity of Meniere's patients. It consists of 25 items in total. The questions are scored between 0-2-4. It is calculated as 'Yes (4 points)', 'Sometimes (2 points)', 'No (0 points)'. Tinnitus level or severity is determined by calculating the total score of the answers given.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: A feeling of fullness and/or pressure in the ear
Description: The feeling of fullness or pressure in the ear was evaluated verbally by receiving yes/no responses from the participants.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Dizziness intensity and frequency
Description: In order to determine the frequency and severity of dizziness, the participants were asked to mark the appropriate score between 1-10 points.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Dizziness disability inventory
Description: The dizziness disability inventory was used to determine the disability level of the individuals participating in our study. It consists of 25 questions in total. The questions are scored between 0-2-4. It is calculated as 'Yes (4 points)', 'Sometimes (2 points)', 'No (0 points)'.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Vertigo symptom scale-short form
Description: The short form of the vertigo symptom scale was used to determine the frequency and duration of vertigo in the individuals participating in our study. The vertigo symptom scale consisting of 8 questions consists of vertigo (VSS-V), and the vertigo symptom scale consisting of 7 questions consists of two subsections consisting of a total of 15 questions: anxiety (VSS-A). Each item; Never (0), Very rarely (1 point), Often (2 points), Often - every week (3 points), Very often - On average, at least twice a week (4 points). The total score ranges from 0 to 60.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Hearing Impairment Scale
Description: The Adult Hearing Impairment Scale was used to determine the effect of the current hearing impairment levels of the individuals participating in our study on their daily living activities. The scale consists of 25 questions in total. The questions are scored between 0-2-4. It is calculated as 'Yes (4 points)', 'Sometimes (2 points)', 'No (0 points)'. Participants mark the most appropriate expression for them.
Study NCT03184155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicardipine
Description: 200 mcg intracoronary nicardipine injection prior to PCI followed by an additional 2-4 doses of 100 mcg intracoronary nicardipine depending on complexity of PCI
Study NCT03184155 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sterile Saline
Description: Bolus of intracoronary sterile saline injection prior to PCI followed by an additional 2-4 doses of sterile saline depending on complexity of PCI
Study NCT06284603 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hyperbaric Oxygen Therapy - HBOT
Description: Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes
Study NCT04505956 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Holmium laser lithotripsy with Moses Technology
Description: Holmium laser energy will be delivered for the ureteroscopic fragmenting of kidney stones. Energy will be generated by the commercial available, FDA approved Lumenis PulseTM P120H laser system and Moses laser fiber. Renal stones will be fragmented using a dusting technique. Moses laser settings will be turned on.
Study NCT04810312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined exercise and nutrition intervention
Description: Back extensor strengthening exercise and nutritional supplementation for 12 weeks
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Cervical Range of Motion (CROM 3) device
Description: Cervical Range of Motion (CROM) device was used to evaluate the sense of proprioception and range of motion (ROM) in the cervical region muscles. A total of six positions were performed: right cervical rotation, left cervical rotation, right cervical lateral flexion, left cervical lateral flexion, cervical extension and cervical flexion.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Temporomandibular joint range of motion assessment
Description: In our study, the temporamandibular joint range of motion (ROM) was evaluated with a ruler specific to each participant in four positions, including mandibular depression, protraction, and right and left lateral deviation.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Posture evaluation with New York posture analysis
Description: The New York Posture Evaluation method was used to obtain information about the general posture correctness of the participants. Posture changes that may occur in 13 different parts of the body, 7 from the side and 6 from the back, including the head, neck, shoulder, back, waist, hip and ankle, were examined in the anatomical position of the individuals. As a result of the observation, the posture of the individual was scored according to whether it was severely bad (1 point), moderately bad (3 points), and straight (5 points). The total score obtained varies between 13-65.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Evaluation of the anterior tilt angle of the head
Description: Anterior tilt angles of the head of the participants were evaluated with photographs taken from the lateral (lateral) side. The anterior tilt angle was calculated as the angle between the line drawn between the C7 cervical spinous process and the tragus and the straight line drawn vertically from C7.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Evaluation of postural balance with the Freemed pressure platform
Description: Postural sway and lower extremity weight transfer were evaluated with the Freemed baropodometric pressure platform (Rome, Italy) system, which has been shown to be valid and reliable.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Static balance assessment with tandem stance test
Description: In our study, the tandem stance test was used for static evaluation. A total of four assessments were made on the participants, first with their right foot in front, eyes open and eyes closed, then left foot in front with eyes open and eyes closed.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Dynamic balance assessment with tandem gait test
Description: In our study, the tandem gait test was used for dynamic evaluation. A straight line was created with a white tape attached to the floor, almost 2 feet away from the 10-foot-long wall. The participant was asked to walk along the line created by taping the heel of the forward foot to touch the toe of the back foot, at a comfortable pace in daily life and with eyes open.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Headache, Temporomandibular pain and Craniocervical pain presence and severity assessment
Description: Headache, temporomandibular pain and craniocervical pain were asked to mark the person from the photographs taken from the front, back and side in the form of a human figure. Pain severity was evaluated with the numerical rating scale (NRS).
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Pain sensitivity assessment in the head, neck, shoulder girdle and upper back region
Description: In our study, muscle tenderness was evaluated by manual pressure algometry and palpation. Muscle tenderness was assessed in the upper and lower regions of the masseter, temporalis, sternocleidomastoid, and upper trapezius muscles on both right and left sides.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: International physical activity questionnaire-measurement of physical activity level with short
Description: The short form of the international physical activity questionnaire was used to determine the physical activity level of the individuals participating in our study. The short form of the international physical activity questionnaire evaluates the last week and consists of a total of 4 sections and 7 questions. Duration of physical activity that requires intense physical effort, such as heavy lifting, soccer, or fast cycling; times of doing moderate physical activities that cause breathing slightly more often than usual; The total duration of walks at work, home, for sports, exercise and hobby, and the total sitting time spent in a day at work, at home or while resting are calculated.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Evaluation of sleep quality with the Pittsburgh sleep quality index
Description: The Pittsburgh Sleep Quality Index (PUKI) was used to evaluate the sleep quality and disturbance of the individuals participating in our study in the last month. It consists of a total of 24 questions. The participant responds to each item according to the frequency between 0-3 points. The total score (0-21 points) from these components indicates whether the sleep quality is good or not.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Evaluation of fatigue with the fatigue severity scale
Description: The Fatigue severity scale was used to evaluate the fatigue status of the individuals participating in our study. The scale uses a scoring system ranging from 1-7, which starts as I do not agree (1 point) and increases gradually towards I agree (7 point). It consists of 9 items in total and people mark the option that suits them.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Evaluation of anxiety-depression status with hospital anxiety and depression scale
Description: The Hospital Anxiety and Depression Scale (HADS) was used to evaluate the anxiety and depression status of the individuals participating in our study. For each item, the participant answers with a four-point (0-3 points) response option. Therefore, the possible score probabilities in line with the answers given are minimum '0' and maximum '21'. The cut-off point for the anxiety subscale is 10 points, while the cut-off point for the depression subscale is 7 points.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: Evaluation of quality of life with short form-12 (SF-12)
Description: The Short form SF-12 Questionnaire was used to evaluate the quality of life of the individuals participating in our study. The summary score of the physical and mental components varies between 0-100, and the higher the score in the components, the better the quality of life.
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: the International Fall Efficiency Scale
Description: The International Fall Activity Scale (UDES) was used to evaluate both the attack and the general fear of falling of the individuals participating in our study. It consists of 16 questions in total. The answer to each question is marked on a scale between 1 and 4 points. Expressions such as I never worry (1 point), I worry a little (2 point), I am very worried (3 point), I am very worried (4 point) are used as the level of anxiety increases as the score increases. The total score obtained ranges from 16 (no worries) to 64 (extremely worried).
Study NCT05844657 — intervention group
Intervention type: OTHER
Intervention: assessment of muscle performance
Description: In our study, the strength of cervical flexors, anterior and oblique trunk flexors, cervical extensor muscles, back extensor muscles, trapezius muscle, and rhomboid major-minor muscles were evaluated. In addition, the endurance of the deep cervical flexor muscles, cervical flexors and cervical extensor muscles were also evaluated.
Study NCT04574869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLS-0071 10 mg/kg
Description: Single dose IV infusion of 10 mg/kg RLS-0071
Study NCT04574869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLS-0071 40 mg/kg
Description: Single dose IV infusion of 40 mg/kg RLS-0071